Lamotrigine Tablet, Extended Release
Product Images NDC 16714-624

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 16714-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Lamotrigine Extended-Release Tablets USP 25 mg label for a 30 tablet bottle. Manufactured by Dr. Reddy's Laboratories Limited in India, and labeled for NorthStar Rx LLC. It includes dosage form as an extended-release oral tablet with storage instructions and medication guide contact information.*

FDA Label Image

Container2 (Container2)

Label for Lamotrigine Extended-Release Tablets USP 50 mg by NorthStar Rx LLC. The packaging states the dosage form as extended-release tablets and strength as 50 mg. It dispenses 30 tablets with a caution to verify product dispensed and instructs pharmacists to provide a medication guide. Storage and manufacturer details by Dr. Reddy's Laboratories Limited, India, are included along with a barcode.*

FDA Label Image

Container3 (Container3)

Label for Lamotrigine Extended-Release Tablets USP 100 mg, oral extended-release tablets. The label states "Rx only" and "Once A Day," with a quantity of 30 tablets. It includes storage instructions, cautions, manufacturer information for NorthStar Rx LLC and Dr. Reddy's Laboratories Limited, and a barcode. The label is primarily blue and white with purple text accents.*

FDA Label Image

Container4 (Container4)

Lamotrigine Extended-Release Tablets, USP 200 mg oral tablet carton label by NorthStar Rx LLC. The label indicates 30 tablets per package with warnings to verify the product and dispense the medication guide. It includes storage instructions and a barcode, and states the tablets are once a day extended-release formulations.*

FDA Label Image

Container5 (Container5)

Label for Lamotrigine Extended-Release Tablets USP 250 mg by NorthStar Rx LLC. The oral tablet packaging contains 30 tablets and includes storage instructions, a barcode, and manufacturing details by Dr. Reddy's Laboratories Limited, India. It indicates prescription use and cautions to verify product dispensed and provide the medication guide to each patient.*

FDA Label Image

Container6

Label for Lamotrigine Extended-Release Tablets, USP 300 mg, oral tablet, extended-release dosage form. The label shows the NDC 16714-627-01, a quantity of 30 tablets, and instructions to dispense the Medication Guide to each patient. The labeler is NorthStar Rx LLC, Memphis, TN, with manufacturing by Dr. Reddy's Laboratories Limited, India. Storage and caution information is also included, along with a barcode.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing responder rates of patients using Lamotrigine extended release tablets (N=70) versus placebo (N=73). The x-axis represents the percent of patients from 0 to 100, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). Two curves are shown: a solid line for Lamotrigine ER and a dashed line for placebo, depicting distribution of patient response rates.*

FDA Label Image

Figure2 (Figure2)

A cumulative responder rate graph comparing Lamotrigine Extended-release Tablets (N=116) to placebo (N=120). The x-axis represents the percent of patients from 100% to 0%, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). The solid line depicts Lamotrigine, and the dashed line depicts placebo, illustrating differences in responder rates across patients.*

FDA Label Image

Pictures (Pictures)

Lamotrigine extended release tablets in six strengths, shown with color, shape, and imprint details: 25 mg yellow round tablets imprinted with R717; 50 mg light green round tablets with R718; 100 mg orange round tablets with R719; 200 mg blue round tablets with R720; 250 mg purple oval tablets with R419; and 300 mg grey modified capsule-shaped tablets imprinted with R428. All tablets are biconvex except the 300 mg which is capsule-shaped, manufactured by NorthStar Rx LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of lamotrigine, an active pharmaceutical ingredient. The structure shows a fused ring system with chlorine atoms, nitrogen, and amino groups, consistent with lamotrigine's known molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.